Skip to content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus
Get the latest shareable resources on coping with COVID-19 from NIMH: https://www.nimh.nih.gov/covid19

Office of Clinical Research (OCR)

Overview

The NIMH Office of Clinical Research (OCR) provides institute-wide coordination of oversight for NIMH-funded clinical research studies and provides strategic guidance and recommendations to NIMH leadership about clinical research initiatives.

OCR provides expertise in the areas of human research protection, data and safety monitoring, clinical trial operations, biostatistics, recruitment monitoring, good clinical practice/protocol compliance monitoring, and certificates of confidentiality. OCR provides consultations to NIMH staff, provides education about clinical research oversight, and serves as a liaison between NIMH and other NIH Institutes/Centers as well as other federal agencies such as the Office for Human Research Protections (OHRP) and Food and Drug Administration (FDA).

Resources

Are you conducting research involving Human Subjects?

If so, please review the NIMH Clinical Research Guidance and Policies and NIH Clinical Trial Requirements for Grants and Contracts.

Acting Director

Anna E. Ordóñez, M.D., M.A.S.
6001 Executive Boulevard, Room 6105
301-443-3241, anna.ordonez@nih.gov